Business
€56 Bln Bayer Eyes Pharmaceutical Manufacturing in Ethiopia
BirrMetrics · last week · Read the Full Story on BirrMetrics

AI SUMMARY
German health giant Bayer AG is exploring local pharmaceutical manufacturing in Ethiopia following a memorandum of understanding signed with the Ministry of Health in December 2025.
- German healthcare multinational Bayer AG is exploring local manufacturing operations in Ethiopia to expand access to essential medicines and maternal healthcare.
- The initiative follows a memorandum of understanding signed between Bayer and the Ethiopian Ministry of Health in December 2025.
- Bayer CEO Bill Anderson held discussions with Finance Minister Ahmed Shide in October 2025 regarding local pharmaceutical production.
- Priority areas of cooperation include pharmaceutical supply chains, maternal and child nutrition, reproductive healthcare, and non-communicable diseases.
- Neither Bayer nor the Ministry has disclosed investment amounts, facility locations, production capacity, or operational timetables.
- Bayer reported 45.58 billion euros in revenue and a net loss of 3.62 billion euros for the 2025 financial year.
- Health Minister Dr. Mekdes Daba reported in August 2026 that domestic market share of locally manufactured medicines rose from 8 percent to 44 percent.
- Ethiopia's pharmaceutical sector strategy features the Kilinto manufacturing zone in Addis Ababa and aims to reach a 4 billion US dollar market by 2030.
Related
Critics Hail Grand Theft Auto VI as a Masterpiece
The Guardian · yesterday
Federal Prosecutors Charge Former Amhara Bank Manager and Borrower Over 200 Million Br 'Phantom Truck' Loan Fraud
Addis Fortune · 2 days ago
Ethiopia to Host Major Pan-African Business Summits in 2027
BirrMetrics · 3 days ago
Japanese Energy Giant Tokyo Gas Joins Dodai’s $16M Series A
Capital Ethiopia · 3 days ago
